Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor

Toru Tsugawa, Rikio Shinohara, Akio Nagasaka, Itsuko Nakano, Fumiko Takeda, Minoru Nagata, Naohisa Oda, Yoshikuni Sawai, Nobuki Hayakawa, Atsushi Suzuki, Mitsuyasa Itoh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

An accerelated polyol pathway in diabetes contributes to the development of diabetic complications. To elucidate diabetic nephropathy involving also renal tubular damage, we measured urinary sorbitol concentration concomitantly with urinary N-acetyl-D-glucosaminidase (NAG) excretion in WBN-kob diabetic rats. Twenty-four-hour urinary sorbitol concentrations increased in the diabetic rats in parallel with whole blood sorbitol concentrations. An increase in 24-h urinary NAG excretion coincided with the elevated urinary sorbitol levels in the diabetic rats. The administration of epalrestat, an aldose reductase inhibitor, reduced the increased whole blood and urinary sorbitol concentrations and urinary NAG excretion concomitantly with renal aldose reductase inhibition in the diabetic rats. These results indicate that diabetic nephropathy involves distorted cell function of renal tubules, and that treatment with epalrestat may prevent at least the progress of the nephropathy.

Original languageEnglish
Pages (from-to)429-435
Number of pages7
JournalJournal of Endocrinology
Volume181
Issue number3
DOIs
Publication statusPublished - 01-06-2004

Fingerprint

Aldehyde Reductase
Sorbitol
Hexosaminidases
Diabetic Nephropathies
Kidney
Diabetes Complications

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Tsugawa, T., Shinohara, R., Nagasaka, A., Nakano, I., Takeda, F., Nagata, M., ... Itoh, M. (2004). Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor. Journal of Endocrinology, 181(3), 429-435. https://doi.org/10.1677/joe.0.1810429
Tsugawa, Toru ; Shinohara, Rikio ; Nagasaka, Akio ; Nakano, Itsuko ; Takeda, Fumiko ; Nagata, Minoru ; Oda, Naohisa ; Sawai, Yoshikuni ; Hayakawa, Nobuki ; Suzuki, Atsushi ; Itoh, Mitsuyasa. / Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor. In: Journal of Endocrinology. 2004 ; Vol. 181, No. 3. pp. 429-435.
@article{bedac1dafda7481c8fd5e1759985b9c1,
title = "Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor",
abstract = "An accerelated polyol pathway in diabetes contributes to the development of diabetic complications. To elucidate diabetic nephropathy involving also renal tubular damage, we measured urinary sorbitol concentration concomitantly with urinary N-acetyl-D-glucosaminidase (NAG) excretion in WBN-kob diabetic rats. Twenty-four-hour urinary sorbitol concentrations increased in the diabetic rats in parallel with whole blood sorbitol concentrations. An increase in 24-h urinary NAG excretion coincided with the elevated urinary sorbitol levels in the diabetic rats. The administration of epalrestat, an aldose reductase inhibitor, reduced the increased whole blood and urinary sorbitol concentrations and urinary NAG excretion concomitantly with renal aldose reductase inhibition in the diabetic rats. These results indicate that diabetic nephropathy involves distorted cell function of renal tubules, and that treatment with epalrestat may prevent at least the progress of the nephropathy.",
author = "Toru Tsugawa and Rikio Shinohara and Akio Nagasaka and Itsuko Nakano and Fumiko Takeda and Minoru Nagata and Naohisa Oda and Yoshikuni Sawai and Nobuki Hayakawa and Atsushi Suzuki and Mitsuyasa Itoh",
year = "2004",
month = "6",
day = "1",
doi = "10.1677/joe.0.1810429",
language = "English",
volume = "181",
pages = "429--435",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "3",

}

Tsugawa, T, Shinohara, R, Nagasaka, A, Nakano, I, Takeda, F, Nagata, M, Oda, N, Sawai, Y, Hayakawa, N, Suzuki, A & Itoh, M 2004, 'Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor', Journal of Endocrinology, vol. 181, no. 3, pp. 429-435. https://doi.org/10.1677/joe.0.1810429

Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor. / Tsugawa, Toru; Shinohara, Rikio; Nagasaka, Akio; Nakano, Itsuko; Takeda, Fumiko; Nagata, Minoru; Oda, Naohisa; Sawai, Yoshikuni; Hayakawa, Nobuki; Suzuki, Atsushi; Itoh, Mitsuyasa.

In: Journal of Endocrinology, Vol. 181, No. 3, 01.06.2004, p. 429-435.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor

AU - Tsugawa, Toru

AU - Shinohara, Rikio

AU - Nagasaka, Akio

AU - Nakano, Itsuko

AU - Takeda, Fumiko

AU - Nagata, Minoru

AU - Oda, Naohisa

AU - Sawai, Yoshikuni

AU - Hayakawa, Nobuki

AU - Suzuki, Atsushi

AU - Itoh, Mitsuyasa

PY - 2004/6/1

Y1 - 2004/6/1

N2 - An accerelated polyol pathway in diabetes contributes to the development of diabetic complications. To elucidate diabetic nephropathy involving also renal tubular damage, we measured urinary sorbitol concentration concomitantly with urinary N-acetyl-D-glucosaminidase (NAG) excretion in WBN-kob diabetic rats. Twenty-four-hour urinary sorbitol concentrations increased in the diabetic rats in parallel with whole blood sorbitol concentrations. An increase in 24-h urinary NAG excretion coincided with the elevated urinary sorbitol levels in the diabetic rats. The administration of epalrestat, an aldose reductase inhibitor, reduced the increased whole blood and urinary sorbitol concentrations and urinary NAG excretion concomitantly with renal aldose reductase inhibition in the diabetic rats. These results indicate that diabetic nephropathy involves distorted cell function of renal tubules, and that treatment with epalrestat may prevent at least the progress of the nephropathy.

AB - An accerelated polyol pathway in diabetes contributes to the development of diabetic complications. To elucidate diabetic nephropathy involving also renal tubular damage, we measured urinary sorbitol concentration concomitantly with urinary N-acetyl-D-glucosaminidase (NAG) excretion in WBN-kob diabetic rats. Twenty-four-hour urinary sorbitol concentrations increased in the diabetic rats in parallel with whole blood sorbitol concentrations. An increase in 24-h urinary NAG excretion coincided with the elevated urinary sorbitol levels in the diabetic rats. The administration of epalrestat, an aldose reductase inhibitor, reduced the increased whole blood and urinary sorbitol concentrations and urinary NAG excretion concomitantly with renal aldose reductase inhibition in the diabetic rats. These results indicate that diabetic nephropathy involves distorted cell function of renal tubules, and that treatment with epalrestat may prevent at least the progress of the nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=3042725371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042725371&partnerID=8YFLogxK

U2 - 10.1677/joe.0.1810429

DO - 10.1677/joe.0.1810429

M3 - Article

C2 - 15171691

AN - SCOPUS:3042725371

VL - 181

SP - 429

EP - 435

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 3

ER -